Head-to-Head in Heart Failure: Comparative Insights on Empagliflozin and Dapagliflozin
Heart failure (HF) remains a leading cause of morbidity and mortality globally, with increasing prevalence driven by aging populations and comorbidities such as diabetes mellitus. Recent advances have highlighted sodium-glucose cotransporter-2 (SGLT2) inhibitors, particularly empagliflozin and dapag...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2025-10-01
|
| Reeks: | Biomedicines |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2227-9059/13/10/2422 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|